ORIGINAL RESEARCH article
Front. Neurosci.
Sec. Neurodegeneration
Volume 19 - 2025 | doi: 10.3389/fnins.2025.1653063
A Novel Fluorescent Probe Triphenylamine Rhodamine-3-Acetic Acid (mRA) for the Detection of Amyloid-β Aggregates in Alzheimer's Disease
Provisionally accepted- 1Alfaisal University, Riyadh, Saudi Arabia
- 2Jamia Millia Islamia Centre for Interdisciplinary Research in Basic Sciences, New Delhi, India
- 3CSIR - Central Leather Research Institute, Chennai, India
- 4King Saud University, Riyadh, Saudi Arabia
- 5King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Amyloid-β (Aβ) is implicated in the pathophysiology of Alzheimer's disease (AD) and plays a significant role in neuronal degeneration. Aβ in solution is essential during the initial stages of developing lead compounds that influence Aβ fibrillation. The tendency of the Aβ peptide to misfold in solution is correlated with the aetiology of AD. Therefore, the early detection of Aβ serves as a critical foundation for diagnostic testing and routine clinical assessment of Alzheimer's disease (AD). Herein, an aggregation-induced fluorescence probe, triphenylamine rhodamine-3acetic acid (mRA), was exploited to detect Aβ aggregates. The fluorescence results showed a strong interaction between the fluorescence probe mRA and Aβ aggregates. mRA specifically binds with high affinity to Aβ aggregatesand the limit of detection (LOD) of Aβ aggregates was 0.12µg/mL. Molecular docking studies showed that the mRA has significant binding affinity towards the Aβ peptide at the N/C-terminal region, with a binding energy of -6.5 kcal/mol. Furthermore, CD studies confirmed that the mRA binds to Aβ aggregates, and its binding induces significant structural alteration of the Aβ aggregates. To further understand the interaction between mRA and Aβ aggregates at the molecular level, thermodynamic properties revealed that Aβ aggregates binding to mRA is a spontaneous process, driven by enthalpy and favoured by entropy.The negative ΔH suggests that hydrogen bonding is a dominant force for the mRA interaction with Aβ aggregates. This study provides a rationale for using mRA as a biosensor for the detection of Aβ aggregates in biological fluids, offering a potential tool for the early diagnosis and monitoring of amyloid progression in Alzheimer's disease (AD)
Keywords: Alzheimer's disease, mRA, fluorescent sensing probe, binding, Thermodynamics, molecular docking, conformational change
Received: 24 Jun 2025; Accepted: 31 Jul 2025.
Copyright: © 2025 Chinnappan, Khan, Mohammad, Allwaibh, Easwaramoorthi, Yaqinuddin, Devansan, Mir and Hassan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Raja Chinnappan, Alfaisal University, Riyadh, Saudi Arabia
Mateen A. Khan, Alfaisal University, Riyadh, Saudi Arabia
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.